GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G.Barekat Pharm (XTEH:BRKT1) » Definitions » PB Ratio

G.Barekat Pharm (XTEH:BRKT1) PB Ratio : 14.93 (As of May. 16, 2024)


View and export this data going back to 2017. Start your Free Trial

What is G.Barekat Pharm PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-16), G.Barekat Pharm's share price is IRR13680.00. G.Barekat Pharm's Book Value per Share for the quarter that ended in Mar. 2017 was IRR916.51. Hence, G.Barekat Pharm's PB Ratio of today is 14.93.

The historical rank and industry rank for G.Barekat Pharm's PB Ratio or its related term are showing as below:

XTEH:BRKT1's PB Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 2.54
* Ranked among companies with meaningful PB Ratio only.

Back to Basics: PB Ratio


G.Barekat Pharm PB Ratio Historical Data

The historical data trend for G.Barekat Pharm's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G.Barekat Pharm PB Ratio Chart

G.Barekat Pharm Annual Data
Trend Mar16 Mar17
PB Ratio
- 1.32

G.Barekat Pharm Semi-Annual Data
Mar16 Mar17
PB Ratio - 1.32

Competitive Comparison of G.Barekat Pharm's PB Ratio

For the Biotechnology subindustry, G.Barekat Pharm's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


G.Barekat Pharm's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, G.Barekat Pharm's PB Ratio distribution charts can be found below:

* The bar in red indicates where G.Barekat Pharm's PB Ratio falls into.



G.Barekat Pharm PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

G.Barekat Pharm's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2017)
=13680.00/916.509
=14.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


G.Barekat Pharm  (XTEH:BRKT1) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


G.Barekat Pharm PB Ratio Related Terms

Thank you for viewing the detailed overview of G.Barekat Pharm's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


G.Barekat Pharm (XTEH:BRKT1) Business Description

Traded in Other Exchanges
N/A
Address
No. 11, 5th Alley, Bucharest Avenue, Argentina Square, Tehran, IRN
G.Barekat Pharm focuses on the introduction of new pharmaceutical fields such as biotechnology, drug delivery which includes nanotechnology, slow release drugs, and new technologies for health, development of cellular molecular industries like tuberculosis, gene therapy, immunotherapy, and tissue technology.

G.Barekat Pharm (XTEH:BRKT1) Headlines

No Headlines